Biopharmaceutical discovery and production in yeast

- Marketed and clinical-stage yeast-derived biopharmaceuticals are commonplace.
- Engineering of N-glycosylation and O-glycosylation is revolutionizing yeast-based expression.
- Yeast provides a powerful tool for lead identification of novel biopharmaceuticals.
- Glycoengineered yeast provides an end-to-end platform for protein therapeutics.